July 22, 2021

Fragile X Syndrome: In Pursuit of a Cure

Date and time

July 22, 2021 ~ July 22, 2021

Dear colleagues and friends,


A global webinar titled “Fragile X Syndrome: In Pursuit of a Cure,” took place on July 22 to commemorate World Fragile X Day. This complimentary event is co-organized with FRAXA Research Foundation. We are delighted that more than 5,000 registered from more than 50 countries worldwide, coming together to raise awareness of this devastating rare disease, and to foster collaborations towards better medicines for patients.


Please click the top banner or here to enjoy the on-demand video.


At WuXi AppTec, we firmly believe in a future where “every drug can be made and every disease can be treated”. That future is only possible if we all work together.

Agenda
  • 08:00 AM - 08:05 AM Welcome

    Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec

    Katie Clapp, President & Co-Founder, FRAXA Research Foundation

  • 08:05 AM - 08:10 AM Collaboration and the voices of the patient advocacy groups

    Katie Clapp, President & Co-Founder, FRAXA Research Foundation

    Alison Singer, President, Autism Science Foundation

    Wendy Bruce, Executive Director, Fragile X Association of Australia

    Yinan Ma, VP, Fragile X Association of China

    Karen Kelm, Board Member, Fragile X Foundation of Canada

    Shalini Kedia, Chairperson, Fragile X Society – India

    Sabrina Muggiati, Creator of the Eu Digo X Program – Brazil

    Paula Gómez Ortega, Coordinator, Fragile X Syndrome Parent's Group – Argentina

    Sandz Fraser, Coordinator, Fragile X South Africa; Owner & Trustee, FiX Africa Special Needs Homeschool

    Nazhi Tabatadze, Clinic coordinator at Fragile X Center, Georgia

    Andrea Lee, Executive Director, Fragile X New Zealand

  • 08:10 AM - 08:40 AM Current clinical studies and practice

    Craig Erickson, Professor of Clinical Psychiatry, Cincinnati Children's Hospital and the University of Cincinnati College of Medicine

    Randi Hagerman, Medical Director, MIND Institute; Distinguished Professor of Pediatrics, Endowed Chair, Fragile X Research, UC Davis Health

    Elizabeth Berry-Kravis, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center

    Moderator: Ted Brown, President, Fragile X Association of Australia

  • 08:40 AM - 08:45 AM Patient story: 3 Australian families
  • 08:45 AM - 09:35 AM New directions in Fragile X Syndrome therapeutics

    Neil Thompson, CSO, Healx

    Mark Bear, Professor of Neuroscience, Picower Institute for Learning and Memory, MIT

    Mark Gurney, Chairman & CEO, Tetra Therapeutics

    Walter Kaufmann, CMO, Anavex Life Sciences; Adjunct Professor of Human Genetics, Emory University

    Charles Large, CEO, Autifony Therapeutics

    Moderator: Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

  • 09:35 AM - 09:40 AM Patient story: The Goss family
  • 09:40 AM - 10:10 AM 10-year vision

    Michael Tranfaglia, Medical Director & CSO, FRAXA Research Foundation

    Alison Singer, President, Autism Science Foundation

    Nahum Sonenberg, Professor & Gilman Cheney Chair in Biochemistry, Goodman Cancer Research Centre, McGill University

    Peter Kind, Director, Simons Initiative for the Developing Brain, Patrick Wild Centre; Professor of Developmental Neuroscience, University of Edinburgh

    Sumantra Chattarji, Senior Professor, National Centre for Biological Sciences, Tata Institute of Fundamental Science, Bangalore, India

    Patricia Cogram, Associate Professor, Department of Genetics, IEB, Faculty of Science, University of Chile

    Shangzhi Huang, Professor of Medical Genetics, Peking Union Medical College

    Elizabeth Berry-Kravis, Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center

  • 10:10 AM - 10:15 AM Closing

    Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec

Speakers
  • Hui Cai
    Hui Cai
    Program Chair, VP and Head of Content, WuXi AppTec
  • Katie Clapp
    Katie Clapp
    President & Co-Founder, FRAXA Research Foundation
  • Alison Singer
    Alison Singer
    President, Autism Science Foundation
  • Wendy Bruce
    Wendy Bruce
    Executive Director, Fragile X Association of Australia
  • Yinan Ma
    Yinan Ma
    VP, Fragile X Association of China
  • Karen Kelm
    Karen Kelm
    Board Member, Fragile X Foundation of Canada
  • Shalini Kedia
    Shalini Kedia
    Chairperson, Fragile X Society – India
  • Sabrina Muggiati
    Sabrina Muggiati
    Creator of the Eu Digo X Program – Brazil
  • Paula Gómez Ortega
    Paula Gómez Ortega
    Coordinator, Fragile X Syndrome Parent's Group – Argentina
  • Sandz Fraser
    Sandz Fraser
    Coordinator, Fragile X South Africa; Owner & Trustee, FiX Africa Special Needs Homeschool
  • Nazhi Tabatadze
    Nazhi Tabatadze
    Clinic coordinator at Fragile X Center, Georgia
  • Andrea Lee
    Andrea Lee
    Executive Director, Fragile X New Zealand
  • Craig Erickson
    Craig Erickson
    Professor of Clinical Psychiatry, Cincinnati Children's Hospital and the University of Cincinnati College of Medicine
  • Randi Hagerman
    Randi Hagerman
    Medical Director, MIND Institute; Distinguished Professor of Pediatrics, Endowed Chair, Fragile X Research, UC Davis Health
  • Elizabeth Berry-Kravis
    Elizabeth Berry-Kravis
    Professor of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center
  • Ted Brown
    Ted Brown
    President, Fragile X Association of Australia
  • Neil Thompson
    Neil Thompson
    CSO, Healx
  • Mark Bear
    Mark Bear
    Professor of Neuroscience, Picower Institute for Learning and Memory, MIT
  • Mark Gurney
    Mark Gurney
    Chairman & CEO, Tetra Therapeutics
  • Walter Kaufmann
    Walter Kaufmann
    CMO, Anavex Life Sciences; Adjunct Professor of Human Genetics, Emory University
  • Charles Large
    Charles Large
    CEO, Autifony Therapeutics
  • Richard Soll
    Richard Soll
    Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec
  • Michael Tranfaglia
    Michael Tranfaglia
    Medical Director & CSO, FRAXA Research Foundation
  • Nahum Sonenberg
    Nahum Sonenberg
    Professor & Gilman Cheney Chair in Biochemistry, Goodman Cancer Research Centre, McGill University
  • Peter Kind
    Peter Kind
    Director, Simons Initiative for the Developing Brain, Patrick Wild Centre; Professor of Developmental Neuroscience, University of Edinburgh
  • Sumantra Chattarji
    Sumantra Chattarji
    Senior Professor, National Centre for Biological Sciences, Tata Institute of Fundamental Science, Bangalore, India
  • Patricia Cogram
    Patricia Cogram
    Associate Professor, Department of Genetics, IEB, Faculty of Science, University of Chile
  • Shangzhi Huang
    Shangzhi Huang
    Professor of Medical Genetics, Peking Union Medical College

EVENTS

wuxi-executive-breakfast-in-basel-the-most-important-innovation-in-drug-r-d-may-be-how-the-industry-works-together
WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together
Reflections from the WuXi Executive Breakfast at Swiss Biotech Day
May 11, 2026
READ MORE

FEATURED

© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy